New Rules Says Medicare Advantage Can't Cover These Treatments More Seniors Rely On

Source Motley_fool

Key Points

  • Centers for Medicare and Medicaid Services is establishing new rules for Medicare Advantage Plans.

  • These rules forbid Medicare Advantage from covering a treatment method retirees are increasingly relying on.

  • The treatments can't be covered because of federal laws.

  • The $23,760 Social Security bonus most retirees completely overlook ›

Since 2018, Medicare Advantage Plans have had flexibility in what they cover, as the Bipartisan Budget Act of 2018 allowed plans to expand coverage to include Special Supplemental Benefits for the Chronically Ill. Supplementary benefits can cover things not directly related to health for people with chronic illnesses, if the services make them healthier or improve their function.

Unfortunately, a new CMS rule that's going into effect in 2026 is prohibiting some common services that could accomplish this goal, despite Medicare Advantage plans trying to cover them -- including one increasingly popular treatment.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Patient being treated by doctor.

Image source: Getty Images.

Medicare Advantage plans asked about covering this popular item

The new CMS rule addresses requests on the part of Medicare Advantage organizations to cover a service senior patients are demanding in increasing numbers: cannabis.

According to the text accompanying the new rule, "CMS has received inquiries from MA organizations about whether they are permitted to offer cannabis-based products as a supplemental benefit. In response to these inquiries, CMS has stated that medical marijuana or derivatives, such as cannabis oil, cannot be covered by MA organizations, as they are illegal substances under Federal law."

Interest in cannabis products has been growing, with an NYU study published revealing 7% of older adults were current cannabis users in 2023, compared to 4.8% in 2021. With more retirees turning to medical cannabis to address health issues, it's not surprising Medicare Advantage Plans need clarity on coverage.

CMS says cannabis can't be included in coverage

CMS has a clear answer now. With the 2026 rule change, CMS listed cannabis as a product that cannot be covered, even as a supplemental benefit.

"Medical marijuana or derivatives, such as cannabis oil, cannot be covered by MA organizations, as they are illegal substances under Federal law," the rule says.

If retirees want these products, they'll need to pay for them by making wise investment choices to generate income to cover the cost.

The $23,760 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income.

One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold, Silver Hit Records as Fed Independence Fears, Iran Unrest Fuel Haven RushGold and silver surged to all-time highs on Monday, propelled by mounting concerns over Federal Reserve independence after the U.S. Justice Department threatened a criminal indictment against the central bank, alongside escalating geopolitical tensions as protests in Iran intensified.
Author  Mitrade
8 hours ago
Gold and silver surged to all-time highs on Monday, propelled by mounting concerns over Federal Reserve independence after the U.S. Justice Department threatened a criminal indictment against the central bank, alongside escalating geopolitical tensions as protests in Iran intensified.
placeholder
Gold Prices Soar to Record High Amid Disappointing U.S. Jobs Data and Geopolitical Tensions Gold prices surged to a record $4,601.17 per ounce as weaker-than-expected U.S. payroll data heightened expectations for Federal Reserve interest rate cuts. Ongoing geopolitical tensions in the Middle East and Venezuela further supported the metal's appeal as a safe haven.
Author  Mitrade
13 hours ago
Gold prices surged to a record $4,601.17 per ounce as weaker-than-expected U.S. payroll data heightened expectations for Federal Reserve interest rate cuts. Ongoing geopolitical tensions in the Middle East and Venezuela further supported the metal's appeal as a safe haven.
placeholder
Oil Rises on Geopolitical Tensions Involving Iran and VenezuelaOil prices extended gains on Friday as traders assessed heightened geopolitical risks, including U.S. President Donald Trump’s warnings against Iran and ongoing efforts to exert influence over Venezuela’s oil exports.
Author  Mitrade
Jan 09, Fri
Oil prices extended gains on Friday as traders assessed heightened geopolitical risks, including U.S. President Donald Trump’s warnings against Iran and ongoing efforts to exert influence over Venezuela’s oil exports.
placeholder
U.S. Dollar Gains as Traders Anticipate Jobs Report and Supreme Court Tariff Ruling The U.S. dollar strengthened in early Asian trading, bolstered by expectations for the upcoming jobs report and pending Supreme Court decision on President Trump’s tariff powers. Analysts remain cautious about potential implications for future interest rates.
Author  Mitrade
Jan 09, Fri
The U.S. dollar strengthened in early Asian trading, bolstered by expectations for the upcoming jobs report and pending Supreme Court decision on President Trump’s tariff powers. Analysts remain cautious about potential implications for future interest rates.
placeholder
XRP Drops 5% After Being Hailed as 2026’s “Hottest Trade”XRP fell back to $2.18 after failing to hold above $2.28, cooling off an early-2026 rally that had been strong enough to earn the token the label of “new cryptocurrency darling” in a recent CNBC segment. The pullback underscores that even strong bullish narratives must contend with significant overhead supply at key technical resistance levels.
Author  Mitrade
Jan 08, Thu
XRP fell back to $2.18 after failing to hold above $2.28, cooling off an early-2026 rally that had been strong enough to earn the token the label of “new cryptocurrency darling” in a recent CNBC segment. The pullback underscores that even strong bullish narratives must contend with significant overhead supply at key technical resistance levels.
goTop
quote